Log in

NASDAQ:COLLCollegium Pharmaceutical News Headlines

$16.65
+0.87 (+5.51 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.77
Now: $16.65
$16.82
50-Day Range
$15.78
MA: $17.16
$18.38
52-Week Range
$10.10
Now: $16.65
$25.59
Volume479,041 shs
Average Volume553,447 shs
Market Capitalization$571.69 million
P/E RatioN/A
Dividend YieldN/A
Beta0.97

Headlines

Collegium Pharmaceutical (NASDAQ COLL) News Headlines

Source:
DateHeadline
Collegium Pharmaceutical (NASDAQ:COLL) Now Covered by Analysts at Needham & Company LLCCollegium Pharmaceutical (NASDAQ:COLL) Now Covered by Analysts at Needham & Company LLC
marketbeat.com - July 25 at 3:15 AM
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Up 5.5%Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Up 5.5%
americanbankingnews.com - August 3 at 9:08 PM
Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ?Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ?
finance.yahoo.com - August 3 at 6:04 PM
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?
finance.yahoo.com - July 29 at 1:15 PM
Collegium Pharmaceutical (COLL) to Release Quarterly Earnings on WednesdayCollegium Pharmaceutical (COLL) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 29 at 6:34 AM
Collegium Pharmaceutical (NASDAQ:COLL) Coverage Initiated at Needham & Company LLCCollegium Pharmaceutical (NASDAQ:COLL) Coverage Initiated at Needham & Company LLC
www.americanbankingnews.com - July 25 at 6:33 AM
Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate UpdateCollegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - July 21 at 7:34 PM
 Analysts Anticipate Collegium Pharmaceutical Inc (NASDAQ:COLL) Will Post Quarterly Sales of $74.87 Million Analysts Anticipate Collegium Pharmaceutical Inc (NASDAQ:COLL) Will Post Quarterly Sales of $74.87 Million
www.americanbankingnews.com - July 21 at 4:01 AM
Collegium Pharmaceuticals - Whether Its Too CheapCollegium Pharmaceuticals - Whether It's Too Cheap
seekingalpha.com - July 20 at 9:28 AM
Zacks: Brokerages Anticipate Collegium Pharmaceutical Inc (NASDAQ:COLL) to Announce $0.24 EPSZacks: Brokerages Anticipate Collegium Pharmaceutical Inc (NASDAQ:COLL) to Announce $0.24 EPS
www.americanbankingnews.com - July 19 at 6:42 AM
Collegium Pharmaceutical Inc to Post FY2020 Earnings of $0.74 Per Share, BWS Financial Forecasts (NASDAQ:COLL)Collegium Pharmaceutical Inc to Post FY2020 Earnings of $0.74 Per Share, BWS Financial Forecasts (NASDAQ:COLL)
www.americanbankingnews.com - July 17 at 8:21 AM
Collegium Pharmaceuticals (COLL) Buy Rating Reaffirmed at Needham & Company LLCCollegium Pharmaceutical's (COLL) Buy Rating Reaffirmed at Needham & Company LLC
www.americanbankingnews.com - July 16 at 11:03 AM
BWS Financial Initiates Coverage on Collegium Pharmaceutical (NASDAQ:COLL)BWS Financial Initiates Coverage on Collegium Pharmaceutical (NASDAQ:COLL)
www.americanbankingnews.com - July 14 at 11:38 AM
Collegium Pharmaceutical Inc (NASDAQ:COLL) Given Average Recommendation of "Hold" by BrokeragesCollegium Pharmaceutical Inc (NASDAQ:COLL) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - July 11 at 5:54 AM
Hedge Funds Keep Buying Collegium Pharmaceutical Inc (COLL)Hedge Funds Keep Buying Collegium Pharmaceutical Inc (COLL)
finance.yahoo.com - June 19 at 2:41 PM
Collegium Pharmaceutical Named one of Boston Business Journal’s 2020 Best Places to WorkCollegium Pharmaceutical Named one of Boston Business Journal’s 2020 Best Places to Work
finance.yahoo.com - June 17 at 5:17 PM
Collegium PharmaceuticalCollegium Pharmaceutical
www.fool.com - June 11 at 12:18 AM
2 Value Stocks That Will Make You Richer in May2 Value Stocks That Will Make You Richer in May
finance.yahoo.com - May 13 at 12:42 PM
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2020 Results - Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 10:28 PM
The Collegium Pharmaceutical (NASDAQ:COLL) Share Price Is Up 116% And Shareholders Are Boasting About ItThe Collegium Pharmaceutical (NASDAQ:COLL) Share Price Is Up 116% And Shareholders Are Boasting About It
finance.yahoo.com - May 8 at 4:08 PM
Collegium Pharmaceutical Inc (COLL) Q1 2020 Earnings Call TranscriptCollegium Pharmaceutical Inc (COLL) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 8 at 4:08 PM
Edited Transcript of COLL earnings conference call or presentation 7-May-20 8:30pm GMTEdited Transcript of COLL earnings conference call or presentation 7-May-20 8:30pm GMT
finance.yahoo.com - May 8 at 4:08 PM
Collegium Pharmaceutical EPS misses by $0.36, misses on revenueCollegium Pharmaceutical EPS misses by $0.36, misses on revenue
seekingalpha.com - May 7 at 5:48 PM
Collegium Reports First Quarter 2020 ProfitabilityCollegium Reports First Quarter 2020 Profitability
finance.yahoo.com - May 7 at 5:48 PM
Collegium Pharmaceutical Q1 2020 Earnings PreviewCollegium Pharmaceutical Q1 2020 Earnings Preview
seekingalpha.com - May 6 at 10:21 PM
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseCollegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - April 30 at 5:05 PM
Collegium Pharmaceutical IncCollegium Pharmaceutical Inc
www.bloomberg.com - April 26 at 12:04 AM
Collegium to Host Conference Call to Discuss First Quarter 2020 Financial Results and Provide Corporate UpdateCollegium to Host Conference Call to Discuss First Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - April 23 at 7:43 PM
Upper Respiratory Tract Infection Treatment Market Research Will Touch A New Level In Upcoming YearUpper Respiratory Tract Infection Treatment Market Research Will Touch A New Level In Upcoming Year
www.marketwatch.com - April 7 at 7:39 AM
Collegium: Unjustified Sell-Off Alters My PlansCollegium: Unjustified Sell-Off Alters My Plans
seekingalpha.com - March 30 at 6:01 PM
The Call On Collegium PharmaceuticalsThe Call On Collegium Pharmaceuticals
seekingalpha.com - March 26 at 2:48 PM
Edited Transcript of COLL earnings conference call or presentation 27-Feb-20 9:30pm GMTEdited Transcript of COLL earnings conference call or presentation 27-Feb-20 9:30pm GMT
finance.yahoo.com - March 22 at 6:28 PM
Top Ranked Growth Stocks to Buy for March 20thTop Ranked Growth Stocks to Buy for March 20th
finance.yahoo.com - March 20 at 11:31 AM
Why Collegium (COLL) Could Be an Impressive Growth StockWhy Collegium (COLL) Could Be an Impressive Growth Stock
www.nasdaq.com - March 10 at 1:11 PM
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q4 2019 Results - Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 28 at 12:10 AM
Collegium Pharmaceutical Inc (COLL) Q4 2019 Earnings Call TranscriptCollegium Pharmaceutical Inc (COLL) Q4 2019 Earnings Call Transcript
www.fool.com - February 28 at 12:10 AM
Collegium Reports Full-Year 2019 Revenue of $296.7 MillionCollegium Reports Full-Year 2019 Revenue of $296.7 Million
finance.yahoo.com - February 27 at 7:10 PM
Collegium Pharmaceutical Q4 2019 Earnings PreviewCollegium Pharmaceutical Q4 2019 Earnings Preview
seekingalpha.com - February 26 at 11:03 PM
Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate UpdateCollegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update
finance.yahoo.com - February 26 at 6:03 PM
Earnings Preview: Collegium Pharmaceutical (COLL) Q4 Earnings Expected to DeclineEarnings Preview: Collegium Pharmaceutical (COLL) Q4 Earnings Expected to Decline
finance.yahoo.com - February 20 at 3:29 PM
Assertio Therapeutics: A Biotech Stock Trading Below Its Cash BalanceAssertio Therapeutics: A Biotech Stock Trading Below Its Cash Balance
seekingalpha.com - February 14 at 7:22 PM
Collegium Announces Closing of the Nucynta Franchise AcquisitionCollegium Announces Closing of the Nucynta Franchise Acquisition
finance.yahoo.com - February 13 at 5:56 PM
Stock To Watch: Collegium Pharmaceutical (COLL)Stock To Watch: Collegium Pharmaceutical (COLL)
www.nasdaq.com - February 12 at 2:28 PM
Collegium prices convertible debt offeringCollegium prices convertible debt offering
seekingalpha.com - February 11 at 1:02 PM
Why Collegium Pharmaceutical Shares Are Sinking TodayWhy Collegium Pharmaceutical Shares Are Sinking Today
www.fool.com - February 10 at 7:50 PM
BRIEF-Collegium Pharmaceutical Prices $125 Mln Convertible Senior Notes OfferingBRIEF-Collegium Pharmaceutical Prices $125 Mln Convertible Senior Notes Offering
www.reuters.com - February 10 at 7:50 PM
Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes OfferingCollegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering
finance.yahoo.com - February 10 at 7:50 PM
Collegium launches convertible debt offering; shares down 10%Collegium launches convertible debt offering; shares down 10%
seekingalpha.com - February 10 at 2:49 PM
BRIEF-Collegium Pharma Announces Proposed Convertible Senior Notes OfferingBRIEF-Collegium Pharma Announces Proposed Convertible Senior Notes Offering
www.reuters.com - February 10 at 9:49 AM
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes OfferingCollegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
finance.yahoo.com - February 10 at 9:49 AM
Cantor Fitzgerald Maintains Overweight on Collegium Pharmaceutical, Raises Price Target to $30Cantor Fitzgerald Maintains Overweight on Collegium Pharmaceutical, Raises Price Target to $30
www.benzinga.com - February 8 at 7:26 PM
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.